Picture EBD Group World of Partnering Opportunities 650x100px

Collaboration › Details

Bruker–Leucadia: investor conference, 201706 supply service Bruker presents at Jefferies Healthcare Conference in New York

	Period	2017-06-08
	Region	New York, NY
	Country	United States (USA)
	Successor	Bruker–Leucadia: investor conference, 201806 supply service Bruker presents at Jefferies Healthcare Conference in New York
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Partner, 2nd	Jefferies LLC
	Group	Leucadia (Group)
	Product	Jefferies 2017 Global Healthcare Conference New York
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen)

Bruker Corporation. (6/2/17). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:

Jefferies 2017 Healthcare Conference, New York, NY
Thursday, June 8, 2017, at 1:30 p.m. Eastern Time
Frank Laukien, President and Chief Executive Officer
Juergen Srega, President, Bruker CALID Group

William Blair 37th Annual Growth Stock Conference, Chicago, IL
Tuesday, June 13, 2017, at 1:30 p.m. Central Time
Frank Laukien, President and Chief Executive Officer
Tony Mattacchione, Senior Vice President and Chief Financial Officer

Goldman Sachs 38th Annual Global Healthcare Conference, Rancho Palos Verdes, CA
Wednesday, June 14, 2017, at 10:40 a.m. Pacific Time
Mark Munch, President, Bruker NANO Group

A live audio webcast of Bruker's Jefferies 2017 Healthcare Conference presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit: www.bruker.com

Contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com